Goldman Sachs initiated coverage on Amneal Pharmaceuticals, noting its headquarters in Bridgewater and Gautam Patel as director.
1 report, 0 independent
Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs initiated coverage on Amneal Pharmaceuticals, noting its headquarters in Bridgewater and Gautam Patel as director.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amneal Pharmaceuticals, Inc.
American publicly traded generics and specialty pharmaceutical company
Nothing else this week.
-
Goldman Sachs
American investment bank
Coverage
Newest first; wire copies grouped- Unknown outlet